Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 11, 2011 - Issue 5
Submit an article Journal homepage
584
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Quality-of-life assessment in schizophrenia: the unfulfilled promise

A George Awad Department of Psychiatry & the Institute of Medical Science, University of Toronto, Toronto, ON, Canada and International Society of CNS Clinical Trials & Methodology (ISCTM), Nashville, TN, USA and Humber River Regional Hospital, 2175 Keele Street, Room 243A, Toronto, ON, M6M 3Z4, Canada. [email protected]
Pages 491-493 | Published online: 09 Jan 2014

References

  • Awad AG, Voruganti LNP. Measuring quality of life of patients with schizophrenia. Pharmacoeconomics11, 32–47 (1997).
  • Lehman A. The well-being of chronic mental patients; assessing their quality of life. Arch. Gen. Psychiatry40, 369–370 (1983).
  • Bachrach LL. Deinstitutionalization: an analytic review and sociological perspective: Rochville (MD) National Institute of Mental Health 1976. Gen. Hosp. Psychiatry7(3), 239–248 (1985).
  • Awad AG. Quality of life of schizophrenic patients on medications and implications for new drug trails. Hosp. Comm. Psychiatry43, 262–265 (1992).
  • Awad AG, Voruganti LNP. International research in psychosis: issues related to the assessment of quality of life. Schizophr. Bull.26, 557–564 (2000).
  • Awad AG, Voruganti LNP, Heselgrave RJ. Preliminary validation of a conceptual model to assess quality of life in schizophrenia. Qual. Life Res.6, 21–26 (1997).
  • Awad AG, Voruganti LNP. Measuring quality of life in patients with schizophrenia – an update. Pharmacoeconomics (2011) (In Press).
  • Awad AG, Voruganti LNP. New antipsychotics, compliance, quality of life and subjective tolerability – are patients better off? Can. J. Psychiatry49, 297–302 (2004).
  • Awad AG, Voruganti LNP. Antipsychotic medications, schizophrenia and the issue of quality of life. In: Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders. Ritsner M, Awad AG (Eds). Springer, The Netherlands, 307–319 (2007).
  • Awad AG, Voruganti LNP. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs18, 877–893 (2004).
  • Davies LM, Drummond MF. The economic burden of schizophrenia. Schizophr. Bull.14, 522–525 (1990).
  • Awad AG, Voruganti LNP. Cost–utility analysis in schizophrenia. J. Clin. Psychiatry60(Suppl. 3), 22–29 (1999).
  • Voruganti LNP, Awad AG et al. Assessing health utilities in schizophrenia – a feasibility study. Pharmacoeconomics17, 273–286 (2000).
  • Mavranezouli I. A review and critique of studies reporting utility values for schizophrenia – related health states. Pharmacoeconomics28, 1109–1121 (2010).
  • Dernovsek MZ, Prevolnik-Rupel V, Tavcar R. Cost–utility analysis – research and practical application. In: Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders. Ritsner M, Awad AG (Eds). Springer, The Netherlands, 373–384 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.